vs
Side-by-side financial comparison of FONAR CORP (FONR) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $13.3M, roughly 1.9× Laird Superfood, Inc.). FONAR CORP runs the higher net margin — 8.0% vs -13.2%, a 21.2% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs 2.4%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
FONR vs LSF — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $13.3M |
| Net Profit | $2.1M | $-1.8M |
| Gross Margin | — | 34.1% |
| Operating Margin | 13.5% | -13.5% |
| Net Margin | 8.0% | -13.2% |
| Revenue YoY | 2.4% | 15.0% |
| Net Profit YoY | 4.7% | -341.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $13.3M | ||
| Q3 25 | $26.0M | $12.9M | ||
| Q2 25 | $27.3M | $12.0M | ||
| Q1 25 | $27.2M | $11.7M | ||
| Q4 24 | $24.9M | $11.6M | ||
| Q3 24 | $25.0M | $11.8M | ||
| Q2 24 | $25.9M | $10.0M | ||
| Q1 24 | $25.7M | $9.9M |
| Q4 25 | $2.1M | $-1.8M | ||
| Q3 25 | $2.3M | $-975.1K | ||
| Q2 25 | $729.3K | $-362.2K | ||
| Q1 25 | $2.5M | $-156.2K | ||
| Q4 24 | $2.0M | $-398.4K | ||
| Q3 24 | $3.1M | $-166.1K | ||
| Q2 24 | $830.4K | $-239.1K | ||
| Q1 24 | $1.9M | $-1.0M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | — | 41.9% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 43.0% | ||
| Q2 24 | — | 41.8% | ||
| Q1 24 | — | 40.0% |
| Q4 25 | 13.5% | -13.5% | ||
| Q3 25 | 14.1% | -7.7% | ||
| Q2 25 | 5.3% | -3.3% | ||
| Q1 25 | 15.2% | -1.9% | ||
| Q4 24 | 11.9% | -4.1% | ||
| Q3 24 | 21.0% | -2.3% | ||
| Q2 24 | 7.4% | -3.4% | ||
| Q1 24 | 16.8% | -11.0% |
| Q4 25 | 8.0% | -13.2% | ||
| Q3 25 | 8.7% | -7.6% | ||
| Q2 25 | 2.7% | -3.0% | ||
| Q1 25 | 9.2% | -1.3% | ||
| Q4 24 | 7.9% | -3.4% | ||
| Q3 24 | 12.6% | -1.4% | ||
| Q2 24 | 3.2% | -2.4% | ||
| Q1 24 | 7.3% | -10.3% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $176.9M | $11.5M |
| Total Assets | $217.2M | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $121.0K | $5.1M | ||
| Q3 25 | $122.0K | $5.1M | ||
| Q2 25 | $56.5M | $3.9M | ||
| Q1 25 | $123.0K | $7.0M | ||
| Q4 24 | $121.0K | $8.3M | ||
| Q3 24 | $136.0K | $7.9M | ||
| Q2 24 | $56.5M | $7.6M | ||
| Q1 24 | $134.0K | $7.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — | ||
| Q1 24 | — | — |
| Q4 25 | $176.9M | $11.5M | ||
| Q3 25 | $174.9M | $12.8M | ||
| Q2 25 | $172.6M | $13.4M | ||
| Q1 25 | $171.9M | $13.3M | ||
| Q4 24 | $169.8M | $13.2M | ||
| Q3 24 | $168.7M | $13.1M | ||
| Q2 24 | $166.0M | $12.6M | ||
| Q1 24 | $165.8M | $12.7M |
| Q4 25 | $217.2M | $19.2M | ||
| Q3 25 | $218.4M | $18.9M | ||
| Q2 25 | $216.9M | $20.4M | ||
| Q1 25 | $214.9M | $21.5M | ||
| Q4 24 | $208.0M | $19.3M | ||
| Q3 24 | $212.3M | $18.8M | ||
| Q2 24 | $214.2M | $18.0M | ||
| Q1 24 | $209.6M | $17.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | $68.4K |
| Free Cash FlowOCF − Capex | $-227.0K | — |
| FCF MarginFCF / Revenue | -0.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | 0.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.0K | $68.4K | ||
| Q3 25 | $1.7M | $1.2M | ||
| Q2 25 | $4.2M | $-2.8M | ||
| Q1 25 | $3.1M | $-1.3M | ||
| Q4 24 | $2.2M | $339.2K | ||
| Q3 24 | $1.7M | $305.8K | ||
| Q2 24 | $4.6M | $642.7K | ||
| Q1 24 | $2.8M | $-422.3K |
| Q4 25 | $-227.0K | — | ||
| Q3 25 | $-177.0K | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $-148.0K | — | ||
| Q2 24 | $4.2M | — | ||
| Q1 24 | $2.6M | — |
| Q4 25 | -0.9% | — | ||
| Q3 25 | -0.7% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 9.4% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | -0.6% | — | ||
| Q2 24 | 16.1% | — | ||
| Q1 24 | 10.2% | — |
| Q4 25 | 1.6% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 3.0% | — | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 5.79× | — | ||
| Q1 25 | 1.26× | — | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | 5.54× | — | ||
| Q1 24 | 1.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
